Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000375644

Medchemexpress LLC N-[4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]phenyl]-1-(2-furanylmethyl)-5-oxo-pyrrolidinecarboxamide | 2784577-71-3 | MFCD00701047 | C24H19ClN4O4 | 1 ML
SDP

Catalog No. 5000375644
Encompass_Preferred

RLX-33 is a potent, selective, and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist. This compound blocks relaxin-3-induced ERK1/2 phosphorylation and can prevent the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats, making it suitable for metabolic syndrome research.

  • Potent and selective RXFP3 antagonist
  • Blood-brain barrier penetrant
  • Blocks relaxin-3-induced ERK1/2 phosphorylation
  • Attenuates R3/I5-induced feeding
  • Good brain penetration
  • Highly protein-bound in rat plasma
  • Useful for metabolic syndrome research

Catalog No. 50-003-75644 Supplier Medchemexpress LLC Supplier No. HY15070010MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

RLX-33 is a potent, selective, and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist. This compound blocks relaxin-3-induced ERK1/2 phosphorylation and can prevent the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats, making it suitable for metabolic syndrome research.

  • Potent and selective RXFP3 antagonist
  • Blood-brain barrier penetrant
  • Blocks relaxin-3-induced ERK1/2 phosphorylation
  • Attenuates R3/I5-induced feeding
  • Good brain penetration
  • Highly protein-bound in rat plasma
  • Useful for metabolic syndrome research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.